Helicobacter pylori and Nonmalignant Diseases
Author:
Boltin Doron,Niv Yaron
Reference61 articles.
1. Agréus L, Svärdsudd K, Nyrén O, Tibblin G (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109(3):671–680 2. Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, Lee E, Brim H, Smoot DT, Ghadyari F, Kamangar F, Razjouyan H (2012) Helicobacter pylori protection against reflux esophagitis. Dig Dis Sci 57(11):2924–2928. doi: 10.1007/s10620-012-2349-3 3. Boltin D, Niv Y (2012) Ghrelin, Helicobacter pylori and body mass: is there an association? Israel Med Assoc J 14(2):130–132 4. Boltin D, Halpern M, Levi Z, Vilkin A, Morgenstern S, Ho SB, Niv Y (2012) Gastric mucin expression in Helicobacter pylori-related, nonsteroidal anti-inflammatory drug-related and idiopathic ulcers. World J Gastroenterol 18(33):4597–4603. doi: 10.3748/wjg.v18.i33.4597 5. Chan FK, Sung JJ, Chung SC, To KF, Yung MY, Leung VK, Lee YT, Chan CS, Li EK, Woo J (1997) Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 350(9083):975–979
|
|